LTF and central nervous system cancer: The Lf receptor is overexpressed in glioma, which enhanced BBB-crossing efficiency after injection of Lf-conjugated magnetic nanocarriers and caused a significant increase in the amount of Lf-magnetic nanocarriers around the vascular region of the brain tumor tissue.